Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Humoral immunity
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==History== The concept of humoral immunity developed based on the analysis of [[antibacterial]] activity of the serum components. [[Hans Buchner (biologist)|Hans Buchner]] is credited with the development of the humoral theory.<ref name= Metch>{{cite book | vauthors = Metchnikoff E | author1-link = Elie Metchnikoff | date = 1905 | url = https://archive.org/details/immunityininfec01metcgoog | title = Immunity in infectious disease | publisher = Cambridge University Press }}</ref> In 1890, Buchner described alexins as "protective substances" that exist in the [[serum (blood)|blood serum]] and other [[Body fluid|bodily fluids]] and are capable of killing [[microorganism]]s. Alexins, later redefined as "complements" by [[Paul Ehrlich]], were shown to be the [[soluble]] components of the innate response that leads to a combination of [[Cellular immunity|cellular]] and humoral immunity. This discovery helped to bridge the features of [[Innate immunity|innate]] and [[acquired immunity]].<ref name= Metch/> Following the 1888 discovery of the bacteria that cause [[diphtheria]] and [[tetanus]], [[Emil von Behring]] and [[Kitasato Shibasaburō]] showed that disease need not be caused by microorganisms themselves. They discovered that cell-free [[filtrate]]s were sufficient to cause disease. In 1890, filtrates of diphtheria, later named [[diphtheria toxin]]s, were used to [[vaccinate]] animals in an attempt to demonstrate that immunized serum contained an [[antitoxin]] that could neutralize the activity of the toxin and could transfer immunity to non-immune animals.<ref name= G.E>{{cite web | vauthors = Gherardi E | url = http://nfs.unipv.it/nfs/minf/dispense/immunology/lectures/files/foundations_immunology.html | title = The experimental foundations of Immunology | archive-url = https://web.archive.org/web/20110530013459/http://nfs.unipv.it/nfs/minf/dispense/immunology/lectures/files/foundations_immunology.html | archive-date=2011-05-30 | work = Immunology Course Medical School | publisher = University of Pavia }}</ref> In 1897, Paul Ehrlich showed that [[antibodies]] form against the plant [[toxin]]s [[ricin]] and [[abrin]], and proposed that these antibodies are responsible for immunity.<ref name= Metch/> Ehrlich, with his colleague von Behring, went on to develop the [[diphtheria antitoxin]], which became the first major success of modern [[immunotherapy]].<ref name= G.E/> The discovery of specified compatible antibodies became a major tool in the standardization of immunity and the identification of lingering [[infection]]s.<ref name= G.E/> {| class="wikitable" style="margin: 1em auto 1em auto" |+ '''Major discoveries in the study of humoral immunity'''<ref name= G.E/> ! Substance|| Activity || Discovery |- | Alexin(s)/[[Complement system|Complement]](s)||Soluble components in the serum<br>that are capable of killing microorganisms ||Buchner (1890),<br>Ehrlich (1892) |- | [[Antitoxins]]||Substances in the serum that can neutralize the activity of toxins, enabling [[passive immunization]] ||von Behring and Shibasaburō (1890) |- | [[Bacteriolysin]]s ||Serum substances that work with the<br>complement proteins to induce bacterial [[lysis]]|| [[Richard Friedrich Johannes Pfeiffer|Richard Pfeiffer]] (1895) |- | Bacterial [[agglutinin]]s <br>and [[precipitin]]s|| Serum substances that aggregate bacteria<br>and [[precipitate]] bacterial toxins ||[[Max von Gruber|von Gruber]] and [[Herbert Durham|Durham]] (1896),<br>[[Rudolf Kraus|Kraus]] (1897) |- | [[Hemolysis (microbiology)|Hemolysins]] || Serum substances that work with complements<br>to lyse red blood cells || [[Jules Bordet]] (1899) |- | [[Opsonin]]s|| Serum substances that coat the outer membrane of foreign substances and enhance the rate of [[phagocytosis]] by [[macrophage]]s||[[Almroth Wright|Wright]] and [[Stewart Ranken Douglas|Douglas]] (1903)<ref name="pmid17788933">{{cite journal | vauthors = Hektoen L | title = Opsonins and Other Antibodies | journal = Science | volume = 29 | issue = 737 | pages = 241–248 | date = February 1909 | pmid = 17788933 | doi = 10.1126/science.29.737.241 | jstor = 1634893 | bibcode = 1909Sci....29..241H | url = https://zenodo.org/record/2404737 }}</ref> |- | [[Antibody]] || Original discovery (1900), antigen-antibody binding hypothesis (1938), produced by B cells (1948), structure (1972), immunoglobulin genes (1976)|| Ehrlich<ref name= Metch/> |}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)